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Experiencing a lower limb amputation (LLA) or spinal cord injury (SCI) is a life changing 30 
event, affecting physical and systemic function as well as having psychological and social 31 
impacts. However, the severity of the physical impairment and/or motor disability 32 
demonstrates a poor relationship with patient reported quality of life, suggesting that other 33 
factors determine such outcomes. As such, holistic health related Quality of Life (QoL) 34 
assessment is an important tool to monitor long-term outcomes. While there are some studies 35 
that have assessed the influence of variables such as age at time of injury occurrence and time 36 
since injury on changes in QoL, there are no systematic reviews which synthesise this 37 
evidence. 38 
Methods/Design: 39 
All follow-up study designs will be included, where data from multiple time points are 40 
presented. Searches will target both SCI and LLA populations where a validated measure of 41 
QoL has been used: Medical Outcome Study Short-Form 36/12 or; the World Health 42 
Organization Quality of Life instruments 100 and BREF. Studies must include adult 43 
participants (≥18 years at time of injury) and detail time since injury event and patient age.  44 
The primary objective is to establish the effects of participant age and time since injury on 45 
QoL scores. Secondary objectives include determining between-group effects (i.e. LLA vs. 46 
SCI).  47 
We will search PubMed, EMBASE, and Web of Science databases, supplemented by hand-48 
searching references within existing review articles and experimental studies. Reviewer pairs 49 
will conduct screening and quality assessment of included papers.  50 
Results will be stratified by impairment, QoL tool, age/time since injury and additional 51 
variables such as sex, race, comorbidity or disease etiology, as appropriate. If sufficient high 52 
quality data exist, a meta-analysis will be conducted. 53 
Discussion: 54 
The results of this systematic review will summarise evidence of how QoL changes across 55 
the life course, relative to both patient age and time since injury, for both LLA and SCI 56 
populations. By enabling a direct comparison of different chronic conditions, disability-57 
specific differences in QoL changes over the life course can be identified. 58 
Systematic Review Registration:  59 
PROSPERO 2018: CRD42018096633 60 
 3 
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Background: 64 
Sustaining a lower limb amputation (LLA) or spinal cord injury (SCI) is a significant event, 65 
with permanent implications for the individual’s future life. The outcomes of both LLA and 66 
SCI are highly individualised and heterogeneous, in part due to variability in the level of 67 
injury/amputation and, at least for SCI, the degree of injury completeness. The reasons for 68 
injury occurrence can also be important, with many LLA cases being related to significant 69 
existing chronic disease and related comorbidities. However, both conditions present a series 70 
of shared outcomes that have a significant impact on aspects of quality of life (QoL) 1. For 71 
example, mobility restriction and differences in appearance lead to shared challenges around 72 
social engagement, perceived isolation and dependency, which can limit community 73 
participation 2–7 and increase risk of depression8–11. Similarly, a general loss of skeletal 74 
muscle mass and restriction of physical activity contribute to long-term health consequences 75 
associated with early ageing 12,13 such as increased risk of cardiovascular and metabolic 76 
diseases 14–16. 77 
 78 
Notwithstanding, several studies have demonstrated that for individuals with a chronic motor 79 
disability the level of physical impairment does not directly correlate with patient reported 80 
quality of life 17–20. QoL scales consider the resultant limitations and consequences of a 81 
disability and assess how these change over time, even when the underlying injury remains.  82 
As such, QoL measures are increasingly being recognised as an important tool for monitoring 83 
long-term outcomes following rehabilitation21–24. Used in combination with assessment of 84 
functional performance, they assist in the recording of changing perceptions and patient 85 
adjustment, as well as their acceptance of life post-injury25,26.  86 
 87 
Researchers in both LLA and SCI communities acknowledge the value of QoL measures as 88 
longitudinal assessment tools 17,27–31. They provide a quantitative mechanism for capturing 89 
changes in post-injury health and broad level treatment outcomes, both for an individual and 90 
for a disability group, relative to population normative data. However, there is a lack of 91 
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homogenous outcome data for both communities and a lack of consensus around QoL scale 92 
selection. 93 
 94 
In part, this is due to the multifaceted nature of QoL as a construct. There are varying 95 
definitions and tools available, built around both conceptual understandings of what 96 
constitutes a person’s quality of life and design considerations specifying what facets a tool is 97 
designed to assess and for which populations. One widely utilised distinction is that between 98 
‘objective’ and ‘subjective’ assessment measures, previously described by Dijkers and Fuhrer 99 
25,26. Several LLA and SCI reviews have followed this construct and divided existing QoL 100 
measures under these headings 27–29,32. Within this distinction, objective measures consider 101 
external definitions of QoL (i.e. those that are societally or culturally defined), whereas 102 
subjective measures focus on an individual’s perceptual assessment of their life relative to 103 
their expectations. 104 
 105 
These distinctions are particularly important to consider when QoL tools have been deployed 106 
longitudinally, or when trying to capture within-population differences in response to 107 
rehabilitation or treatment. Both components of QoL should be reflected when attempting to 108 
create more personalised rehabilitation or recovery pathways for specific patient sub-groups. 109 
For example, there are ongoing shifts in the population demographics for both SCI and LLA 110 
33–35. For SCI, age at onset is subject to considerable variation globally, with increasingly 111 
aging populations in more economically developed countries (MEDC) highlighted as a 112 
potential future public health challenge 36. Similarly for LLA, there is significant variation 113 
between countries for age at onset, etiology and incidence 37,38.  This variation encompasses a 114 
complex landscape, with regional public health provision intersecting with clinical advances.  115 
 116 
Regardless, within both conditions, mean and upper age at onset and potentially life 117 
expectancy is increasing for both populations, in particular within MEDCs 34,35,39–41. 118 
Furthermore, it has been noted that a bimodal distribution may be forming for both 119 
conditions, 35,42 with traumatic injuries relating to misadventure or conflict continuing to 120 
occur at younger ages, while the proportion whose injury results from age or lifestyle related 121 
factors, such as vascular disease for LLA or frailty-related falls for SCI, increases. 122 
 123 
This potentially growing divide in age at time of injury occurrence raises questions around 124 
identifying rehabilitation or treatment requirements for different age groups 43,44. It also has 125 
 5 
implications when considering functional and QoL outcomes across the life course and when 126 
selecting QoL instruments 45–47. 127 
 128 
Previous research has been undertaken comparing SCI and LLA population QoL outcomes to 129 
population norms and healthy controls27, but no cross-population comparisons have been 130 
reported. This leads to important questions regarding how the comparative success of long-131 
term rehabilitation and recovery pathways can be evaluated and optimized to sustain QoL. By 132 
directly comparing the QoL scores at an individual health domain level (e.g. Physical Health, 133 
Psychological, Social Relationship and Environment for WHOQOL-BREF) we may gain 134 
insight into the condition specific challenges of living with these disabilities. 135 
 136 
There is a significant challenge in assessing long-term quality of life changes relative to age, 137 
due in part to a lack of longitudinal data in both SCI and LLA populations, particularly for 138 
those who suffered an injury in later life 19,34,48,49. As population demographics change and 139 
post-operative life expectancy rates can be expected to improve, the detail of variation in 140 
QoL relative to time since injury and age at onset holds increasing importance 33,45. There is 141 
currently a lack of consensus around the relationship between QoL with age at time of injury 142 
and time since injury, both for persons with SCI 48 and those with LLA 50,51. 143 
This review intends to provide a synthesis of these previously unassessed variables, alongside 144 
etiology characteristics, to address this issue. This is required as the emergence of 145 
increasingly divided points of disability incidence may necessitate changes in care provision 146 
or categorisation.  147 
 148 
Aim 149 
The primary purpose of this systematic review is to evaluate current evidence to determine 150 
the independent and combined effects of age at time of injury and time since injury on health-151 
related quality of life in persons with Spinal Cord Injury or Lower Limb Amputation. Where 152 
there are a sufficient number and quality of articles, analyses will be performed to determine 153 
differences in the effects of these variables, between groups and over time. The secondary 154 
purpose of the review is to determine the potential effects of other variables (e.g. sex, 155 





This protocol follows the principles of The Cochrane Handbook for Systematic reviews and 160 
the final report will conform to the Preferred Reporting Items for Systematic Reviews and 161 
Meta-Analyses52,53. The Preferred Reporting Items for Systematic Reviews and Meta-162 
Analyses (PRISMA-P) process will be followed, as presented in Additional File 1. 163 
This protocol was registered with the PROSPERO International Prospective Register of 164 
Systematic Reviews database (registration number CRD42018096633). 165 
 166 
QoL Tool Selection 167 
 168 
When deciding which quality of life (QoL) measures to include in this review, we required 169 
scales which: i) had been assessed for validity and reliability in both SCI and LLA 170 
populations; ii) were in common use and, if possible; iii) reflected both aspects of subjective 171 
and objective QoL assessment25.  172 
Several reviews have summarised both the utilisation and validity of QoL tools for SCI and 173 
LLA populations27–31,48,54,55. These indicate that the WHOQOL-BREF56 and Medical 174 
Outcomes SF-3657 are in common use and considered amongst the best available generic 175 
tools for both groups. The SF-36 is an objective tool and the WHOQOL-BREF is considered 176 
subjective, although it has objective elements27,32,54.  177 
The SF-36 has been reported as one of the most widely evaluated generic health measures58, 178 
and this is consistent with utilization in LLA and SCI populations48,55,59. The SF-12 is also 179 
used in both populations, retains the same sub-domains as the SF-36 and has been shown to 180 
have good agreement with the longer form60. While the WHOQOL-BREF has been used less 181 
frequently, particularly in studies of persons with LLA, it has been extensively assessed 182 
24,32,61–63 and is sometimes preferred because of its mixed subjective/objective features29.  183 
These scales are both subdivided into domains allowing sub-component analysis. 184 
Furthermore, the convergence and agreement between the two scales has been previously 185 
assessed and found acceptable in SCI and 27 other health conditions, although LLA has not 186 
been investigated as an independent health condition32,61. For completeness, although it is 187 
used less frequently, data derived from the full WHOQOL-10064 survey will also be included.   188 
 189 
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Eligibility Criteria for consideration of inclusion 190 
 191 
We will adopt an inclusive approach where all follow-up study designs, where data from 192 
multiple time points are presented, with any publication date, written in the English 193 
Language, will be eligible if they present data on adults (≥18 years at time of injury) with 194 
either SCI or LLA.  195 
Studies will be required to utilise either (or combinations of) the Medical Outcome Study 196 
Short-Form 36/12 or the World Health Organization Quality of Life instruments 100 and 197 
BREF to assess patient health related quality of life and provide sufficient detail to extract 198 
domain level scores. That is, the WHOQOL instruments define 4 domains (i.e. Physical 199 
Health, Psychological, Social relationship and Environment), while the Medical Outcome 200 
Study details two domains, Physical and Mental, which have four subsections each. 201 
Additionally, studies must detail the sample’s age and/or the time since injury event/onset 202 
and present data from at least two follow-up time points. Furthermore, only LLA studies 203 
examining above ankle amputation will be included. 204 
 205 
Information sources and Literature search strategy  206 
The literature search strategy will be based around the digital libraries of PubMed, EMBASE, 207 
and Web of Science Core Collection. This will be supplemented through a hand search of 208 
references within existing review articles and selected experimental studies.  209 
Specific search strategies will utilise both medical subject headings (MeSH) or database-210 
specific equivalents and free text terms to maximize study identification. These are detailed 211 
in Additional File 2. 212 
 213 
Study Selection Process 214 
The citations of all records retrieved with be downloaded to Mendeley Desktop 65 (Version 215 
1.17.13) for record keeping and duplicate removal. The title and abstract of entries will then 216 
be transferred to a Microsoft Excel 66 spreadsheet for appraisal and selection for full paper 217 
review. To minimise the risk of investigator bias, a team of four independent reviewers will 218 
be divided into two reviewer pairs to conduct all levels of screening and quality assessment. 219 
Use of multiple reviewer pairs will allow the rotation of citation assessment at abstract and 220 
full paper stages to further reduce reviewer bias. Discrepancies will be resolved by within-221 
pair discussion and then by inclusion of an additional independent reviewer until consensus is 222 
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reached. Cohen’s kappa statistic 67 will be calculated to determine the inter-rater agreement 223 
for study inclusion.  224 
 225 
Data extraction 226 
Data to be extracted will include basic descriptive characteristics of the study (e.g. study 227 
design, year of publication, sample size, country of study); baseline participant characteristics 228 
both for injury type (LLA/SCI) and level of injury (i.e. above/below knee amputation; 229 
American Spinal Injury Association (ASIA) Impairment Scale and level of injury), etiology 230 
of injury (i.e. trauma, vascular, cancer etc), personal characteristics (i.e. age, sex, 231 
comorbidity, time since injury, social status) and outcome results (i.e. quality of life scale 232 
used and scores across domains/sub-domains). The data extraction form will be pilot tested 233 
by two reviewers on 10 papers68 and modified to reflect the level and specificity of data 234 
available. 235 
 236 
Data synthesis 237 
The results of the systematic review will be summarised descriptively and quantitatively, 238 
assuming the appropriate data are available. Data will be considered across the two QoL 239 
scales, with results grouped by scale sub-domains, injury type and sub-population. We will 240 
conduct separate sub-group analyses across these strata and provide composite information 241 
where possible. Normative population data, where available, will also be referenced for 242 
comparative analysis. As age and time since injury are key variables, where these data are not 243 
available, additional data will be requested from corresponding authors.  244 
Where sufficient data for meta-analysis are available, a mixed effects meta-regression model 245 
using the ‘metafor’ package in R (version 3.2.4, R Foundation for Statistical Computing, 246 
Vienna, Austria) will be used69. The modifying effects of age and time since injury on QoL 247 
outcomes will be evaluated as the change associated with a two standard deviation (SD) 248 
change in the predictor (i.e. a typically low vs. a typically high value)70. The random effects 249 
in the model will be a between-study SD, representing the typical difference in the true value 250 
of the effect in different study settings, plus a within-study random effect to account for 251 
within-study repeated measurements. 252 
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Quality assessment 253 
The risk of bias within individual studies will be assessed using the Cochrane Risk of Bias 254 
Tool 52 for randomized trials, and the NIH Quality Assessment Tool for Observational Cohort 255 
and Cross-Sectional Studies71. Regardless of quality score, papers will be included in the 256 
final review and analyses, but summarized descriptively according to risk of bias. 257 
Corresponding authors will be contacted if insufficient details exist to confidently assess the 258 
risk of bias in individual studies. 259 
Discussion: 260 
This systematic review and meta-analysis is designed to assess the independent and 261 
combined effects of age at time of injury and elapsed time since injury on quality of life in 262 
persons with chronic SCI and LLA.  263 
By taking a cross-population perspective, this review will highlight potential discrepancies in 264 
QoL outcome for each group across the various sub-domains of the two QoL scales. This 265 
may also allow further comparative analysis between the SF-36 and WHOQOL BREF scales 266 
for use in disabled populations. Given the heterogeneity of aetiology for both conditions, a 267 
comparative view of rehabilitative outcomes is necessary to identify any global failings or 268 
successes of rehabilitative practice for the different conditions. 269 
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SF-36 – Medical Outcomes Study 36-Item Short-Form Health Survey 276 
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SF-12 - Medical Outcomes Study 12-Item Short-Form Health Survey 277 
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